Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,057.02 5.99 (0.57%) as of 4:30 Mon 7/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.66(B)
Last Volume: 383,195 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 57 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goldstein Joseph L Director   –       •      –    2014-03-25 4 A $0.00 $0 D/D 10,000 10,000     -
   Baker Charles A Director   –       •      –    2014-03-24 4 AS $300.09 $4,540,001 D/D (15,000) 9,000     -
   Baker Charles A Director   –       •      –    2014-03-24 4 OE $23.84 $357,600 D/D 15,000 24,000     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-24 4 B $299.01 $94,511,734 I/I 306,945 18,790,310 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-21 4 B $313.12 $98,008,222 I/I 305,115 18,483,365 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-20 4 B $325.94 $19,033,511 I/I 57,957 18,178,250 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-19 4 B $326.44 $3,195,651 I/I 9,746 18,120,293 1.5     -
   Brown Michael S Director   –       •      –    2014-03-17 4 AS $333.42 $668,573 D/D (2,000) 14,662     -
   Brown Michael S Director   –       •      –    2014-03-17 4 OE $33.42 $66,840 D/D 2,000 16,662     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-17 4 B $328.32 $19,755,234 I/I 60,128 18,110,547 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-14 4 B $326.77 $18,251,215 I/I 55,583 18,050,419 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-12 4 B $325.40 $73,964,412 I/I 220,995 17,994,836 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-11 4 B $328.82 $60,043,336 I/I 180,710 17,773,841 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-10 4 B $325.34 $65,687,435 I/I 199,822 17,593,131 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-07 4 B $327.77 $80,405,733 I/I 241,818 17,393,309 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-07 4 B $304.21 $22,093,655 I/I 69,873 17,151,491 1.5     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-06 4 B $338.64 $27,305,546 I/I 80,404 17,081,618 1.5     -
   Brown Michael S Director   –       •      –    2014-03-06 4 A $0.00 $0 I/I 2,700 2,700     -
   Sanofi-Aventis 10% Owner   –       –       •   2014-03-03 4 B $328.00 $85,070,118 I/I 251,594 17,001,214 1.5     -
   Vagelos P Roy Chairman of the Board   •       •      –    2014-02-27 4 OE $9.49 $899,952 D/D 70,879 140,839     -
   Brown Michael S Director   –       •      –    2014-02-27 4 S $335.00 $335,000 D/D (1,000) 14,662     -
   Brown Michael S Director   –       •      –    2014-02-26 4 OE $57.11 $57,110 D/D 1,000 15,662     -
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-02-25 4 AS $336.89 $4,030,823 D/D (11,871) 63,102     -
   Goldstein Joseph L Director   –       •      –    2014-02-25 4 S $338.86 $338,860 D/D (1,000) 0     -
   Goldberg Murray A SVP Administration & Asst Secr   •       –      –    2014-02-24 4 D $342.63 $6,289,316 D/D (18,356) 74,973     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 57 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us